AUROPHARMA · Aurobindo Pharma Ltd.

Analysis date: 2026-09-29 · Full technical + VCP detail

STRUCTURAL STAGE: BREAKOUT ACTIONABLE: NO STAGE QUALITY: PASS DATA QUALITY: PASS

Essential fundamentals

Separate from OmmAlpha technical and ML ranking.

Refreshed 2026-09-27 06:20:05

Market cap₹98,505 Cr

P/E (TTM)26.73

P/B2.62

EPS (TTM)₹64.04

EPS growth YoY23.0%

Revenue growth YoY16.3%

ROE—

Operating margin15.2%

Net margin10.6%

Debt / Equity21.3%

Current ratio—

Dividend yield24.0%

Book value / share₹652.39

Revenue (TTM)₹34,935 Cr

Net income (TTM)₹3,713 Cr

Beta0.03

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

Source: Yahoo Finance via yfinance. Fundamentals refresh automatically in rotating batches; they are not calculated from Zerodha OHLC data. EPS growth uses reported quarterly EPS where available.

Price & trend

Close1,705.30

SMA 201,685.69

Price vs SMA201.16%

SMA 501,639.23

Price vs SMA504.03%

SMA 1501,485.69

Price vs SMA15014.78%

SMA 2001,409.79

Price vs SMA20020.96%

200-SMA risingYES

Trend TemplatePASS

Momentum & relative strength

RSI-14 56.0

ADX-1423.4

+DI-1423.1

-DI-1416.4

RS percentile88.8

Momentum score25.6

3M return9.8%

6M return30.4%

12M return52.6%

Volatility, range & liquidity

ATR-1435.94

ATR %2.11%

Bollinger width 206.55%

Relative volume 201.26x

60-session base depth13.1%

52W high1,740.00

Below 52W high-1.99%

52W low1,066.80

Above 52W low59.85%

Avg volume 20760,325

Avg volume 50897,409

Avg traded value 201,284,571,273

VCP structure

Structural stage BREAKOUT

Actionable NO

Stage quality PASS

VCP score81.2

Pivot1,717.00

Distance to pivot0.68% below pivot

Contraction count2

Final contraction4.8%

Volume 5/201.08x

Breakout volume1.26x

Volume dry-upNO

Contractions

5.5% 4.8%

ML decision support

PAUSED FOR V8 RETRAIN

V8 stages are active, but the latest production ML model could not be verified from its actual training CSV as an OmmAlpha-v8 model. Scores are intentionally hidden. Verification: no_model_run.

Interactive price chart

Daily / Weekly candles · SMA20 / SMA50 / SMA200 · volume · quarterly EPS · EPS growth

Open TradingView

AUROPHARMA Move cursor over chart

SMA20 SMA50 SMA200 Quarterly EPS EPS YoY growth VCP Pivot

Daily/Weekly: candle timeframe · mouse wheel: zoom · drag: pan · arrows: move time/price · crosshair: exact values Charting library: TradingView Lightweight Charts™

Selection gate audit

Rule Version PASS

Stage Quality PASS

Data Quality PASS

Stage Pre Breakout FAIL

Trend Template PASS

Sma200 Rising PASS

Near 52w High PASS

Rs PASS

Liquidity PASS

Atr PASS

Below Pivot PASS

Pivot Proximity PASS

Base Integrity PASS

Market Ok FAIL

Threshold Min Rs PASS

Threshold Max Below 52w High Pct PASS

Threshold Max Below Pivot Pct PASS

Hard Gates PASS

Failed Gates PASS

Actionable FAIL

Detector notes

V8 structural pivot 1,717.00 (CONFIRMED_RESISTANCE_CLUSTER, touches 3)
2 contraction(s); tightening 100%
final contraction 4.8%
0.68% below structural pivot
5D/20D volume 1.08x
day/20D breakout volume 1.26x
separate quality gate PASS (4/4 checks)
active base floor 1,623.00 (2026-09-16)
active-base distance limit 10.0% below pivot
confirmed breakout is holding a healthy retest of structural pivot
stage detail HEALTHY_RETEST